Hólyagrák: nyitott vizsgálatok itt: Lengyelország
17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. nov. 10.. Ask the study team whether a trial fits you.
3. fázisToborozTrial-stage medicine
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
- Where
- Bialystok, Bydgoszcz, Lublin, Przemyśl, Tarnów, Torun, Wiele, Wroclaw
- Age
- 18 év and over
- People
- 641 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06319820Regiszter frissítve: 2026-11-03
2. fázisToborozTrial-stage medicine
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
- Where
- Lodz, Opole, Poznan, Przemyśl
- Age
- 18 év and over
- People
- 240 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07475806Regiszter frissítve: 2026-11-02
3. fázisToborozTrial-stage medicine
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Where
- Bydgoszcz, Poznan, Warsaw
- Age
- 18 év and over
- People
- 454 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06510374EU 2024-512029-10-00Regiszter frissítve: 2026-10-30
3. fázisToborozTrial-stage medicine
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
- Where
- Bydgoszcz, Poznan, Warsaw
- Age
- 18 év and over
- People
- 250 worldwide
- Run by
- Ferring Pharmaceuticals
See details and how to joinNCT06545955EU 2024-512177-27-01Regiszter frissítve: 2026-10-30
1/2. fázisToborozTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Cracow, Lodz, Rzeszów, Siedlce, Skorzewo
- Age
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064EU 2023-509632-26-00Regiszter frissítve: 2026-10-26
3. fázisToborozTrial-stage medicine
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Where
- Bydgoszcz, Koszalin, Krakow, Skorzewo, Sosnowiec, Warsaw, Wrocaw
- Age
- 18 év and over
- People
- 450 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07218380EU 2025-522855-25-00Regiszter frissítve: 2026-10-07
1. fázisToborozTrial-stage medicine
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
- Age
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483EU 2023-510061-10-00Regiszter frissítve: 2026-10-01
2. fázisToborozTrial-stage medicine
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Where
- Poznan, Tarnów
- Age
- 18 év and over
- People
- 308 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06833073EU 2024-517335-46-00Regiszter frissítve: 2026-10-01
3. fázisToborozResearch participation
A Phase III, Open-Label, Randomised, Multicentre, Global Study of Adjuvant Datopotamab Deruxtecan in Combination With Rilvegostomig in Participants With High-risk Muscle Invasive Urothelial Carcinoma.
- Where
- Gdansk, Koszalin, Poznan, Siedlce, Skorzewo, Wroclaw
- Age
- 18 év to 64 év
- People
- 262 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-525030-57-00EU 2025-525030-57-00Regiszter frissítve: 2026-09-28
2. fázisToborozResearch participation
A study to find out if enfortumab vedotin given with pembrolizumab helps people with muscle-invasive bladder cancer keep their bladder.
- Where
- Cracow, Lodz, Poznan, Przemyśl, Tarnów, Warszawa, Wroclaw
- Age
- 18 év and over
- People
- 88 worldwide
- Run by
- Astellas Pharma Global Development Inc.
See details and how to join2025-524488-18-00EU 2025-524488-18-00Regiszter frissítve: 2026-09-21
3. fázisToborozResearch participation
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study with Durvalumab
- Where
- Bialystok, Bydgoszcz, Elblag, Lodz, Olsztyn, Szczecin, Warsaw
- Age
- 18 év and over
- People
- 87 worldwide
- Run by
- Astrazeneca AB
See details and how to joinNCT05303532EU 2023-507337-22-00Regiszter frissítve: 2026-09-08
3. fázisToborozTrial-stage medicine
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
- Where
- Bydgoszcz, Gdansk, Katowice, Lublin, Olsztyn, Opole, Szczecin, Wroclaw
- Age
- 18 év and over
- People
- 70 worldwide
- Run by
- UroGen Pharma Ltd.
See details and how to joinNCT06774131EU 2024-519343-15-00Regiszter frissítve: 2026-09-03
1/2. fázisToborozTrial-stage medicine
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Gdansk, Poznan, Warsaw
- Age
- 18 év and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776EU 2023-508002-20-00Regiszter frissítve: 2026-08-19
3. fázisToborozTrial-stage medicine
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Where
- Gdansk, Koszalin, Poznan, Siedlce, Skórzewo, Wroclaw
- Age
- 18 év and over
- People
- 915 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07720284Regiszter frissítve: 2026-07-22
2. fázisToborozResearch participation
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
- Where
- Cracow, Gdynia
- Age
- 18 év and over
- People
- 101 worldwide
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780EU 2022-502654-14-00Regiszter frissítve: 2026-05-19
No phaseToborozResearch participation
Occupational Situation and Return to Work of Urological Patients
- Where
- Krakow
- Age
- 18 év and over
- People
- 2000
- Run by
- Jagiellonian University
See details and how to joinNCT07088536Regiszter frissítve: 2026-03-03
No phaseToborozResearch participation
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Gdansk, Warsaw
- Age
- 18 év and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767Regiszter frissítve: 2024-08-26
Minden vizsgálat (Hólyagrák) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.